Pharmadule Morimatsu

Pharmadule Morimatsu

Stockholm, Sweden· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $45M

Overview

Pharmadule Morimatsu is a pioneer and leader in the modular delivery of pharmaceutical manufacturing facilities, founded in Sweden in 1986. As part of the Morimatsu Group, it combines process equipment expertise with modular construction to offer turnkey solutions, boasting over 80 projects delivered worldwide. Its business model focuses on reducing client risk through fixed-price contracts, accelerated timelines, and flexible, expandable designs, primarily serving pharmaceutical and consumer products companies.

Drug DeliveryMedical Devices

Technology Platform

Modular delivery concept for pharmaceutical manufacturing facilities; design and fabrication of prefabricated, cGMP-compliant modules in controlled factory settings for rapid on-site assembly.

Funding History

2
Total raised:$45M
Series B$40M
Grant$5M

Opportunities

Strong demand driven by the need for faster, more flexible pharmaceutical manufacturing capacity, especially for biologics and cell/gene therapies, and by supply chain regionalization trends.
The integrated turnkey solution with Morimatsu's process equipment provides a unique competitive offering.

Risk Factors

Exposure to geopolitical and supply chain risks due to primary manufacturing in China; vulnerability to cyclical swings in pharmaceutical capital expenditure; and execution risks associated with large, fixed-price engineering projects.

Competitive Landscape

Competes with traditional Engineering, Procurement, and Construction (EPC) firms and other specialized modular facility providers. Differentiation lies in its pioneering history, fixed-price/firm-schedule model, massive manufacturing scale within Morimatsu Group, and integrated offering of facilities with process equipment.